These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33681411)

  • 1. Functional Dyskinesias following Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Report of Three Cases.
    Maciel R; Zúñiga-Ramírez C; Munhoz RP; Zurowski M; Fasano A
    Mov Disord Clin Pract; 2021 Jan; 8(1):114-117. PubMed ID: 33681411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.
    Mossner JM; Patil PG; Chou KL
    J Neural Transm (Vienna); 2019 Nov; 126(11):1479-1483. PubMed ID: 31494731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient disabling dyskinesias: a predictor of good outcome in subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Gago MF; Rosas MJ; Linhares P; Ayres-Basto M; Sousa G; Vaz R
    Eur Neurol; 2009; 61(2):94-9. PubMed ID: 19039227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease.
    Kim JH; Chang WS; Jung HH; Chang JW
    Yonsei Med J; 2015 Sep; 56(5):1316-21. PubMed ID: 26256974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyskinesia-inducing lead contacts optimize outcome of subthalamic stimulation in Parkinson's disease.
    Bouthour W; Béreau M; Kibleur A; Zacharia A; Tomkova Chaoui E; Fleury V; Benis D; Momjian S; Bally J; Lüscher C; Krack P; Burkhard PR
    Mov Disord; 2019 Nov; 34(11):1728-1734. PubMed ID: 31571277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation.
    Apetauerova D; Ryan RK; Ro SI; Arle J; Shils J; Papavassiliou E; Tarsy D
    Mov Disord; 2006 Aug; 21(8):1277-9. PubMed ID: 16637040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.
    Vitek JL; Jain R; Chen L; Tröster AI; Schrock LE; House PA; Giroux ML; Hebb AO; Farris SM; Whiting DM; Leichliter TA; Ostrem JL; San Luciano M; Galifianakis N; Verhagen Metman L; Sani S; Karl JA; Siddiqui MS; Tatter SB; Ul Haq I; Machado AG; Gostkowski M; Tagliati M; Mamelak AN; Okun MS; Foote KD; Moguel-Cobos G; Ponce FA; Pahwa R; Nazzaro JM; Buetefisch CM; Gross RE; Luca CC; Jagid JR; Revuelta GJ; Takacs I; Pourfar MH; Mogilner AY; Duker AP; Mandybur GT; Rosenow JM; Cooper SE; Park MC; Khandhar SM; Sedrak M; Phibbs FT; Pilitsis JG; Uitti RJ; Starr PA
    Lancet Neurol; 2020 Jun; 19(6):491-501. PubMed ID: 32470421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of deep brain stimulation on levodopa-induced dyskinesias and striatal oscillatory local field potentials in a rat model of Parkinson's disease.
    Alam M; Capelle HH; Schwabe K; Krauss JK
    Brain Stimul; 2014; 7(1):13-20. PubMed ID: 24126192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyskinesias and grip control in Parkinson's disease are normalized by chronic stimulation of the subthalamic nucleus.
    Wenzelburger R; Zhang BR; Poepping M; Schrader B; Müller D; Kopper F; Fietzek U; Mehdorn HM; Deuschl G; Krack P
    Ann Neurol; 2002 Aug; 52(2):240-3. PubMed ID: 12210799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study.
    Santin MDN; Voulleminot P; Vrillon A; Hainque E; Béreau M; Lagha-Boukbiza O; Wirth T; Montaut S; Bardinet E; Kyheng M; Rolland AS; Voirin J; Drapier S; Durif F; Eusebio A; Giordana C; Auzou N; Houeto JL; Hubsch C; Jarraya B; Laurencin C; Maltete D; Meyer M; Rascol O; Rouaud T; Tir M; Moreau C; Corvol JC; Proust F; Grabli D; Devos D; Tranchant C; Anheim M;
    Mov Disord; 2021 Mar; 36(3):750-757. PubMed ID: 33022101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic parkinson's disease: one year follow-up.
    Pinter MM; Alesch F; Murg M; Seiwald M; Helscher RJ; Binder H
    J Neural Transm (Vienna); 1999; 106(7-8):693-709. PubMed ID: 10907728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's disease.
    Brodsky MA; Hogarth P; Nutt JG
    Mov Disord; 2006 Sep; 21(9):1487-90. PubMed ID: 16721730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained dyskinesias following elective cessation and reactivation of chronic subthalamic nucleus deep brain stimulation for a surgical procedure.
    Shih LC; Vanderhorst V; Papavassiliou E; Tarsy D
    Neuromodulation; 2011; 14(6):512-4; discussion 514. PubMed ID: 21854491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
    Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
    J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.
    Okun MS; Gallo BV; Mandybur G; Jagid J; Foote KD; Revilla FJ; Alterman R; Jankovic J; Simpson R; Junn F; Verhagen L; Arle JE; Ford B; Goodman RR; Stewart RM; Horn S; Baltuch GH; Kopell BH; Marshall F; Peichel D; Pahwa R; Lyons KE; Tröster AI; Vitek JL; Tagliati M;
    Lancet Neurol; 2012 Feb; 11(2):140-9. PubMed ID: 22239915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Efficient Is Subthalamic Deep Brain Stimulation in Reducing Dyskinesia in Parkinson's Disease?
    Juhász A; Deli G; Aschermann Z; Janszky J; Harmat M; Makkos A; Kovács M; Komoly S; Balás I; Dóczi T; Büki A; Kovács N
    Eur Neurol; 2017; 77(5-6):281-287. PubMed ID: 28391276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient selected goals and satisfaction after bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Nam SK; Yoo D; Lee WW; Jang M; Kim HJ; Kim YE; Park HR; Ehm G; Yang HJ; Yun JY; Shin C; Kim HJ; Jeon B
    J Clin Neurosci; 2020 Jun; 76():148-153. PubMed ID: 32312629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation.
    Elia AE; Dollenz C; Soliveri P; Albanese A
    Eur J Neurol; 2012 Jan; 19(1):76-83. PubMed ID: 21645174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.